Shofu Inc.

7979.T
Medical Instruments & Supplies
2026/08/23 Updated
Market Cap: $523.6M (¥83.2B)
Stock Price: $14.71 (¥2,339)
Exchange Rate: 1 USD = ¥158.98

【Shofu】Strengthening Collaboration in Dental Materials Business and Shareholder Relations|June 2026

Shofu, with Mitsui Chemical as its largest shareholder, is working to strengthen collaboration in the dental materials business. As of June 2026, its voting rights ownership ratio is 20.13%. The Company is focused on future business development and stabilizing shareholder relationships.

Importance:
Page Updated: June 16, 2026
IR Disclosure Date: June 16, 2026

Key Figures

  • Voting rights ownership ratio: 20.13% (Mitsui Chemical)
  • No transactions with controlling shareholders
  • Stabilization of shareholder relationships and strengthening of business collaboration

AI要約

Performance Overview

This information is from IR on June 16, 2026, indicating that Shofu’s voting rights ownership ratio as of March 31, 2026, is 20.13%, with Mitsui Chemical Corporation as its largest shareholder. The Company has entered into business and capital alliances with Mitsui Chemical in the dental materials segment, strengthening cooperation in research & development, production, and sales. Moving forward, they aim to enhance corporate strength and global competitiveness while maintaining stable relationships with shareholders.

Shareholder Relations and Future Outlook

Mitsui Chemical is an important affiliate of the Company, and key management decisions are made by the Board of Directors. As of June 2026, there are no transactions with controlling shareholders, and the Company’s management independence is maintained to a certain extent. The Company will continue to pursue business expansion and competitiveness through collaboration in the dental materials segment, while aiming to sustain and strengthen relationships with shareholders.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Shofu

Company overview · Stock price · Financial data · All IR

View company page →